Subscribe

2002 IDSA Guidelines for the Neutropenic Cancer Patient Who Is Still Febrile After 3 to 5 Days of Empiric Antibiotic Therapy

Specialty:

Infectious Diseases
Clinical Pharmacology & Toxicology
Hematology Oncology

Objective:

ICD-10:

Description:

A cancer patient with febrile neutropenia is evaluated after the first 3 to 5 days of empiric therapy. If the patient is still febrile then changes to the regimen may be necessary. The authors are from the Infectious Diseases Society of America (IDSA) and multiple hospitals in the North America and Europe.

To read more or access our algorithms and calculators, please log in or register.

RECENT TWEETS

medal descover
medal iphone